Jean‐Luc Harousseau

33.0k citations
319 papers · 15.8k indexed · 1 hit paper · h-index 69
  • Hematology top 0.01%
    • Multiple Myeloma Research and Treatments 191
    • Acute Myeloid Leukemia Research 49
    • Hematopoietic Stem Cell Transplantation 39
  • Oncology top 0.2%
    • Cancer Treatment and Pharmacology 50
    • Peptidase Inhibition and Analysis 43
  • Genetics top 0.2%
    • Chronic Lymphocytic Leukemia Research 43
    • Protein Degradation and Inhibitors 82
    • Lymphoma Diagnosis and Treatment 41

Jean‐Luc Harousseau

312 papers receiving 15.3k citations

Hit Papers

Subcutaneous versus intravenous administration of bortezo...6612011202620162021200400600

Peers

Jean‐Luc Harousseau
Comparison fields: 5 of 143
  • Hematology 11.0k
  • Oncology 7.0k
  • Genetics 2.6k
  • Molecular Biology 8.8k
  • Pathology and Forensic Medicine 2.2k
Replace Mario Boccadoro with:
Mario Boccadoro Italy
Hartmut Goldschmidt Germany
Hervé Avet‐Loiseau France
Faith E. Davies United Kingdom
Guido Tricot United States
Raymond Alexanian United States
Michel Attal France
Frits van Rhee United States
Joan Bladé Spain
Thierry Façon France
Jean‐Luc Harousseau relative to Mario Boccadoro Italy Mario Boccadoro's profile →
Citations per field
00.5×1.5×
Mario Boccadoro · 1×
Citations per year

Countries citing papers authored by Jean‐Luc Harousseau

Since Specialization
Citations

This map shows the geographic impact of Jean‐Luc Harousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Luc Harousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Luc Harousseau more than expected).

Fields of papers citing papers by Jean‐Luc Harousseau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Luc Harousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Luc Harousseau. The network helps show where Jean‐Luc Harousseau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jean‐Luc Harousseau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean‐Luc Harousseau Line = papers co-authored together Jean‐Luc Harousseau links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20244
3 202311
4 20231
5 202222
6 202153
7 20144
8 201310
9 201096
10 201092
11 201026
12 2010103
13 2010298
14 2009148
15 2008269
16 200752
17
Effets secondaires cutanéomuqueux de l’hydroxyurée : étude prospective sur 27 patients
20065
18
Cutaneomucous side effects of hydroxyurea: prospective study on 27 patients.
20063
19 20058
20 199734

About Jean‐Luc Harousseau

Jean‐Luc Harousseau is a scholar working on Hematology, Genetics and Oncology, having authored 319 papers that have together received 15.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (191 papers), Protein Degradation and Inhibitors (82 papers), Cancer Treatment and Pharmacology (50 papers), Acute Myeloid Leukemia Research (49 papers), Chronic Lymphocytic Leukemia Research (43 papers), Peptidase Inhibition and Analysis (43 papers), Lymphoma Diagnosis and Treatment (41 papers) and Hematopoietic Stem Cell Transplantation (39 papers). The work is most often cited by research in Hematology (11.0k citations), Oncology (7.0k citations) and Genetics (2.6k citations). Jean‐Luc Harousseau has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Régis Bataille, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Thierry Façon, Nöel Milpied, Martine Amiot, Xavier Leleu, Mohamad Mohty and Stéphane Minvielle. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Cancer and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026